Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Regulatory News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Regulatory News
CFDA Solicits Comments on Draft Rules for Registration Approval o... 3/21/2018
CFDA Issues Pharmaceutical Research Guidance for Phase III Trials... 3/16/2018
CFDA Issues Technical Guidelines for Genotoxicity Study of Drugs 3/15/2018
CFDA Seeks Comments on Matters Related to Custom Clearance of API... 3/14/2018
China Reorganizes Drug Regulation in Gigantic Government Shakeup 3/13/2018
CDE Solicits Comments for Proposed Technical Guidance Documents 3/13/2018
CDE Seeks Feedbacks on Draft Rules for of Drug R&D and Evalua... 3/12/2018
FDA Warns OTC Drugmakers in China and Hong Kong 3/7/2018
CFDA To Be Split and Reorganized, Again? 3/5/2018
Review of Biologic Registration Applications and Approvals in Chi... 3/5/2018
Review of Chemical Drug Registration Applications and Approvals i... 3/5/2018
CFDA Issues Drug Clinical Guidelines for Anti-depressants 2/27/2018
China Approved 39 Import Drugs in 2017 2/26/2018
Page:6/6    Total number of articles:163  :[<<][6][First]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links